Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Investor Presentation

 In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), we submit herewith the Investors' Presentation of the Company, with respect to Business Overview of Themis Medicare Limited ('the Company'). Further, a copy of the same is also available on the website of the Company, viz., https://www.themismedicare.com Kindly take the above on record and acknowledge receipt of the same.
09-02-2023
Bigul

THEMIS MEDICARE LTD. - 530199 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited has received the below mentioned intimation / request for Loss of Share Certificate / issuance of duplicate share certificate from the following shareholder: Folio No Name Certificate No. Distinctive No. No. of Shares 00005606 NATVAR PATEL 8151 3531001 - 3531100 100 We shall issue the duplicate Share Certificate only after the necessary formalities are carried out by the Shareholder. This may be taken as compliance under the Listing Regulations. Kindly take the same on record and acknowledge receipt.
09-02-2023
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 This is to inform with reference to our letter dated February 06, 2023, regarding Earning Conference Call, which was scheduled on Wednesday, 8th February, 2023 at 04:30 PM. has been rescheduled to Friday, 10th February, 2023 at 12:30 PM. Details of meeting attached below. Note: The schedule of the aforesaid meetings is subject to change. The changes may happen due to exigencies on the part of Fund / Broking House / Company. No Unpublished Price Sensitive Information (UPSI) will be discussed in the meetings/calls. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.themismedicare.com
07-02-2023
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 This is to inform with reference to our letter dated January 31, 2023, regarding Earning Conference Call, which was scheduled on Tuesday, 7th February, 2023 at 04:30 PM has been rescheduled to Wednesday, 8th February, 2023 at 04:30 PM. Details of meeting attached below. Note: The schedule of the aforesaid meetings is subject to change. The changes may happen due to exigencies on the part of Fund / Broking House / Company. No Unpublished Price Sensitive Information (UPSI) will be discussed in the meetings/calls. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.themismedicare.com
06-02-2023
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In terms of Regulations 47 of SEBI(LODR) Regulations, 2015 the Company has published the Un-Audited Financial Results for the quarter and Nine months ended 31st December,2022 in ''Indian Express'' (English) edition and in Financials Express'' (Gujarati) edition on Saturday, 04th February, 2023. Further, in pursuance of Regulation 30 read with Schedule III (A) (12) please find enclosed the copy of Newspaper articles as published in the above mentioned newspapers. Kindly take the same on record and acknowledge receipt.
06-02-2023

Guj Themis Standalone December 2022 Net Sales at Rs 28.17 crore, up 51.4% Y-o-Y

 NULL
04-02-2023
Bigul

THEMIS MEDICARE LTD. - 530199 - Results- Financial Results For December 31, 2023(Quarterly)

 The Board of Directors at its meeting held today, considered and approved the Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine months ended 31st December 2022. A copy of Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine months ended 31st December, 2022 together with Limited Review Report issued by Krishaan & Co., Chartered Accountants is enclosed herewith. This may be taken as compliance under the Listing Regulations.
03-02-2023
Bigul

THEMIS MEDICARE LTD. - 530199 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 03Rd February, 2023

 The Board of Directors at its meeting held today, considered and approved the Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine months ended 31st December 2022. A copy of Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine months ended 31st December, 2022 together with Limited Review Report issued by Krishaan & Co., Chartered Accountants is enclosed herewith. This may be taken as compliance under the Listing Regulations.
03-02-2023
Bigul

THEMIS MEDICARE LTD. - 530199 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited has received the below mentioned intimation / request for Loss of Share Certificate / issuance of duplicate share certificate from the following shareholder: Folio No Name Certificate No. Distinctive No. No. of Shares 00010747 RAVI KANT 7255 3441401 - 3441500 100 We shall issue the duplicate Share Certificate only after the necessary formalities are carried out by the Shareholder. This may be taken as compliance under the Listing Regulations.
02-02-2023
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 The Company is scheduling Earning Conference Call on Tuesday, 7th February, 2023 at 04:30 PM. Details of meeting attached below. Note: The schedule of the aforesaid meetings is subject to change. The changes may happen due to exigencies on the part of Fund / Broking House / Company. No Unpublished Price Sensitive Information (UPSI) will be discussed in the meetings/calls. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.themismedicare.com This is for your information and record.
31-01-2023
Next Page
Close

Let's Open Free Demat Account